Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic

• Amandine Gagneux-Brunon,
• Clémentine Schilte,
• Arnauld Garcin,
• Nathalie Jolly,
• Muriel Vray,
• Laura Schaeffer,
• Xavier Duval,
• Bruno Hoen,
• Elisabeth Botelho-Nevers

Affiliations

Amandine Gagneux-Brunon

Department of Infectious diseases, University Hospital of Saint-Etienne

Clémentine Schilte

Center for Translational Science, Institut Pasteur

Arnauld Garcin

Unité de Recherche Clinique, Innovation et Pharmacologie, University Hospital of Saint-Etienne

Nathalie Jolly

Center for Translational Science, Institut Pasteur

Muriel Vray

Unité d’Epidémiologie des Maladies Emergentes, Institut Pasteur, INSERM

Laura Schaeffer

Unité d’Epidémiologie des Maladies Emergentes, Institut Pasteur, INSERM

Xavier Duval

Inserm CIC-1425, AP-HP, Hôpital Universitaire Bichat; Inserm UMR-1137 IAME; Université Paris Diderot, UFR de Médecine-Bichat

Bruno Hoen

Institut Pasteur

Elisabeth Botelho-Nevers

Department of Infectious diseases, University Hospital of Saint-Etienne